{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:57:17Z","timestamp":1792605437517,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Amyotrophic lateral sclerosis (ALS) individuals carrying the hexanucleotide repeat expansion (HRE) in the <jats:italic>C9orf72<\/jats:italic> gene (C9Pos) have been described as presenting distinct features compared to the general ALS population (C9Neg). We aim to identify the phenotypic traits more closely associated with the HRE and analyse the role of the repeat length as a modifier factor.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We studied a cohort of 960 ALS patients (101 familial and 859 sporadic cases). Motor phenotype was determined using the MRC scale, the lower motor neuron score (LMNS) and the Penn upper motor neuron score (PUMNS). Neuropsychological profile was studied using the Italian version of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS), the Frontal Behavioral Inventory (FBI), the Beck Depression Inventory-II (BDI-II) and the State-Trait Anxiety Inventory (STAI). A two-step PCR protocol and Southern blotting were performed to determine the presence and the size of <jats:italic>C9orf72<\/jats:italic> HRE, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>C9orf72<\/jats:italic> HRE was detected in 55\/960 ALS patients. C9Pos patients showed a younger onset, higher odds of bulbar onset, increased burden of UMN signs, reduced survival and higher frequency of concurrent dementia. We found an inverse correlation between the HRE length and the performance at ECAS ALS-specific tasks (<jats:italic>P<\/jats:italic>\u2009=\u20090.031). Patients also showed higher burden of behavioural disinhibition (<jats:italic>P<\/jats:italic>\u2009=\u20091.6\u2009\u00d7\u200910<jats:sup>\u20134<\/jats:sup>), lower degrees of depression (<jats:italic>P<\/jats:italic>\u2009=\u20090.015) and anxiety (<jats:italic>P<\/jats:italic>\u2009=\u20090.008) compared to C9Neg cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study provides an extensive characterization of motor, cognitive and behavioural features of <jats:italic>C9orf72<\/jats:italic>-related ALS, indicating that the <jats:italic>C9orf72<\/jats:italic> HRE size may represent a modifier of the cognitive phenotype.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-022-11433-z","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T08:02:41Z","timestamp":1667030561000},"page":"898-908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"270","author":[{"given":"Eleonora","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Maranzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Peverelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Solca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Colombrita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Tiloca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Bonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Silani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5963-7426","authenticated-orcid":false,"given":"Nicola","family":"Ticozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"11433_CR1","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"R Mejzini","year":"2019","unstructured":"Mejzini R, Fletcher LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA (2019) ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci 13:1310. https:\/\/doi.org\/10.3389\/fnins.2019.01310","journal-title":"Front Neurosci"},{"key":"11433_CR2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1212\/WNL.0000000000003067","volume":"87","author":"ME Umoh","year":"2016","unstructured":"Umoh ME, Fournier C, Li Y, Polak M, Shaw L, Landers JE, Hu W, Gearing M, Glass JD (2016) Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology 87:1024\u20131030. https:\/\/doi.org\/10.1212\/WNL.0000000000003067","journal-title":"Neurology"},{"key":"11433_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.661447","volume":"15","author":"J Smeyers","year":"2021","unstructured":"Smeyers J, Banchi EG, Latouche M (2021) C9ORF72: what it is, what it does, and why it matters. Front Cell Neurosci 15:661447. https:\/\/doi.org\/10.3389\/fncel.2021.661447","journal-title":"Front Cell Neurosci"},{"key":"11433_CR4","doi-asserted-by":"publisher","first-page":"2528.e7","DOI":"10.1016\/j.neurobiolaging.2012.06.008","volume":"33","author":"A Ratti","year":"2012","unstructured":"Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, Tiloca C, D\u2019Ascenzo C, Bagarotti A, Pesnati V, Ranieri M, Gagliardi S, Calini D, Mazzini L, Taroni F, Corti S, Ceroni M, Oggioni GD, Lin K, Powell JF, Sorar\u00f9 G, Ticozzi N, Comi GP, D\u2019Alfonso S, Gellera C, Silani V, SLAGEN Consortium (2012) C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33:2528.e7-e14. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.06.008","journal-title":"Neurobiol Aging"},{"key":"11433_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/brain\/awr366","volume":"135","author":"A Chio","year":"2012","unstructured":"Chio A, Borghero G, Restagno G, Mora G, Drepper C, Trajnor BJ, Sendtner M, Brunetti M, Ossola I, Calvo A, Pugliatti M, Sotgiu MA, Murru MR, Marrosu MG, Marrosu F, Marinou K, Mandrioli J, Sola P, Caponnetto C, Mancardi G, Mandich P, La Bella V, Spataro R, Conte A, Monsurr\u00f2 MR, Tedeschi G, Pisano F, Bartolomei I, Salvi F, Lauria Pinter G, Simone I, Logroscino G, Gambardella A, Quattrone A, Lunetta C, Volanti P, Zollino M, Penco S, Battistini S, ITALSGEN consortium, Renton AE, Majounie A, Abramzon Y, Conforti FL, Giannini F, Corbo M, Sabatelli M (2012) Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 135:784\u2013793. https:\/\/doi.org\/10.1093\/brain\/awr366","journal-title":"Brain"},{"key":"11433_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-011-0937-5","volume":"123","author":"H Stewart","year":"2012","unstructured":"Stewart H, Rutherford NJ, Briemberg H, Briemberg H, Krieger C, Cashman N, Fabros M, Baker M, Fok A, DeJesus-Hernandez M, Eisen A, Rademakers R, Mackenzie IRA (2012) Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol 123:409\u2013417. https:\/\/doi.org\/10.1007\/s00401-011-0937-5","journal-title":"Acta Neuropathol"},{"key":"11433_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jnnp-2012-303507","volume":"84","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, Toledo JB, Boller A, Bekisz J, Chandrasekaran K, McCarty Wood E, Shaw LM, Woo JH, Cook PA, Wolk DA, Arnold SE, Van Deerlin VM, McCluskey LF, Elman L, Lee VM-Y, Trojanowski JQ, Grossman M (2013) Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 84:163\u2013169. https:\/\/doi.org\/10.1136\/jnnp-2012-303507","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11433_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fnins.2019.00485","volume":"13","author":"F Trojsi","year":"2019","unstructured":"Trojsi F, Siciliano M, Femiano C, Santangelo G, Lunetta C, Calvo A, Moglia C, Marinou K, Ticozzi N, Ferro C, Scial\u00f2 C, Sorar\u00f9 G, Conte A, Falzone YM, Tortelli R, Russo M, Sansone VA, Chi\u00f2 A, Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Sabatelli M, Riva N, Logroscino G, Messina S, Fasano A, Monsurr\u00f2 MR, Tedeschi G, Mandrioli J (2019) Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: the effect of male sex on survival of C9orf72 positive patients. Front Neurosci 13:485. https:\/\/doi.org\/10.3389\/fnins.2019.00485","journal-title":"Front Neurosci"},{"key":"11433_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/21678421.2013.765485","volume":"14","author":"JS Snowden","year":"2013","unstructured":"Snowden JS, Harris J, Richardson A, Rollinson S, Thompson JC, Neary D, Mann DMA, Pickering-Brown S (2013) Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72. Amyotroph Lateral Scler Frontotemporal Degener 14:172\u2013176. https:\/\/doi.org\/10.3109\/21678421.2013.765485","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11433_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/21678421.2021.1962355","volume":"23","author":"A Ratti","year":"2022","unstructured":"Ratti A, Peverelli S, D\u2019Adda E, Colombrita C, Gennuso M, Prelle A, Silani V (2022) Genetic and epigenetic disease modifiers in an Italian C9orf72 family expressing ALS, FTD or PD clinical phenotypes. Amyotroph Lateral Scler Frontotemporal Degener 23:292\u2013298. https:\/\/doi.org\/10.1080\/21678421.2021.1962355","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11433_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/mp.2015.159","volume":"21","author":"I Gijselinck","year":"2016","unstructured":"Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Engelborghs S, De Bleecker J, Ivanoiu A, Deryck O, Edbauer D, Zhang M, Heeman B, B\u00e4umer V, Van den Broeck M, Mattheijssens M, Peeters K, Rogaeva E, De Jonghe P, Cras P, Martin J-J, de Deyn PP, Cruts M, Van Broeckhoven C (2016) The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry 21:1112\u20131124. https:\/\/doi.org\/10.1038\/mp.2015.159","journal-title":"Mol Psychiatry"},{"key":"11433_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000542","volume":"7","author":"J Roggenbuck","year":"2021","unstructured":"Roggenbuck J (2021) C9orf72 and the Care of the Patient With ALS or FTD. Progress and Recommendations After 10 Years. Neurol Genet 7:e542. https:\/\/doi.org\/10.1212\/NXG.0000000000000542","journal-title":"Neurol Genet"},{"key":"11433_CR13","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","volume":"29","author":"DA Amado","year":"2021","unstructured":"Amado DA, Davidson BL (2021) Gene therapy for ALS: a review. Mol Ther 29:3345\u20133358. https:\/\/doi.org\/10.1016\/j.ymthe.2021.04.008","journal-title":"Mol Ther"},{"key":"11433_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","volume":"17","author":"H-J Westeneng","year":"2018","unstructured":"Westeneng H-J, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, K\u00f6rner S, Ringer TM, R\u00f6diger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chi\u00f2 A, Hardiman O, Moons KGM, Velfink JH, van den Berg LH (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17:423\u2013433. https:\/\/doi.org\/10.1016\/S1474-4422(18)30089-9","journal-title":"Lancet Neurol"},{"key":"11433_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Scler Other Motor Neuron Disord 1:293\u2013299. https:\/\/doi.org\/10.1080\/146608200300079536","journal-title":"Amyotrophic Lateral Scler Other Motor Neuron Disord"},{"key":"11433_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neurol.2018.09.017","volume":"175","author":"P Corcia","year":"2019","unstructured":"Corcia P, Beltran S, Lautrette G, Bakkouche S, Couratier P (2019) Staging amyotrophic lateral sclerosis: a new focus on progression. Rev Neurol 175:277\u2013282. https:\/\/doi.org\/10.1016\/j.neurol.2018.09.017","journal-title":"Rev Neurol"},{"key":"11433_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3109\/21678421.2015.1125502","volume":"17","author":"MS Devine","year":"2016","unstructured":"Devine MS, Ballard E, O\u2019Rourke P, Kiernan MC, Mccombe PA, Henderson RD (2016) Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Scler and Frontotemporal Degener 17:184\u2013190. https:\/\/doi.org\/10.3109\/21678421.2015.1125502","journal-title":"Amyotrophic Lateral Scler and Frontotemporal Degener"},{"key":"11433_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/mus.26764","volume":"61","author":"C Quinn","year":"2020","unstructured":"Quinn C, Edmundson C, Dahodwala N, Elman L (2020) Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis. Muscle Nerve 61:508\u2013511. https:\/\/doi.org\/10.1002\/mus.26764","journal-title":"Muscle Nerve"},{"key":"11433_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/21678421.2016.1183679","volume":"17","author":"B Poletti","year":"2016","unstructured":"Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, Monti A, Zago S, Calini D, Tiloca C, Doretti A, Verde F, Ratti A, Ticozzi N, Abrahams S, Silani V (2016) The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 17:489\u2013498. https:\/\/doi.org\/10.1080\/21678421.2016.1183679","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11433_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/21678421.2020.1732424","volume":"21","author":"IK Gosselt","year":"2020","unstructured":"Gosselt IK, Nijboer TCW, Van Es MA (2020) An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Frontotemporal Degener 21:324\u2013336. https:\/\/doi.org\/10.1080\/21678421.2020.1732424","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11433_CR21","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/wnl.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546\u20131554. https:\/\/doi.org\/10.1212\/wnl.51.6.1546","journal-title":"Neurology"},{"key":"11433_CR22","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini M-L, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456\u20132477. https:\/\/doi.org\/10.1093\/brain\/awr179","journal-title":"Brain"},{"key":"11433_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, Hortob\u00e1gyi T, Rosenfeld J, Silani V, Ince PG, Turner MR (2017) Amyotrophic lateral sclerosis\u2014frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18:153\u2013174. https:\/\/doi.org\/10.1080\/21678421.2016.1267768","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11433_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1590\/1516-4446-2012-1048","volume":"35","author":"YP Wang","year":"2013","unstructured":"Wang YP, Gorenstein C (2013) Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatry 35:416\u2013431. https:\/\/doi.org\/10.1590\/1516-4446-2012-1048","journal-title":"Braz J Psychiatry"},{"key":"11433_CR25","volume-title":"Manual for the State-Trait Anxiety Inventory","author":"CD Spielberger","year":"1983","unstructured":"Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto"},{"key":"11433_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ajhg.2013.01.011","volume":"92","author":"J Beck","year":"2013","unstructured":"Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC, Rossor MN, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet 92:345\u2013353. https:\/\/doi.org\/10.1016\/j.ajhg.2013.01.011","journal-title":"Am J Hum Genet"},{"key":"11433_CR27","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1212\/WNL.0000000000001012","volume":"83","author":"J Theuns","year":"2014","unstructured":"Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crostiers D, Corsmit E, Elinck E, Sharma M, Kr\u00fcger R, Lesage S, Brice A, Chung SJ, Kim M-J, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan E-K, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschl\u00e4nder A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maranganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Broeckhoven V, GEO-PD Consortium (2014) Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. Neurology 83:1906\u20131913. https:\/\/doi.org\/10.1212\/WNL.0000000000001012","journal-title":"Neurology"},{"key":"11433_CR28","doi-asserted-by":"publisher","first-page":"936.e13","DOI":"10.1016\/j.neurobiolaging.2013.09.037","volume":"35","author":"N Ticozzi","year":"2014","unstructured":"Ticozzi N, Tiloca C, Calini D, Gagliardi S, Altieri A, Colombrita C, Cereda C, Ratti A, Pezzoli G, Borroni B, Goldwurm S, Padovani A, Silani V (2014) C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. Neurobiol Aging 35:936.e13-e17. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.09.037","journal-title":"Neurobiol Aging"},{"key":"11433_CR29","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1212\/WNL.0000000000011093","volume":"96","author":"B Iazzolino","year":"2021","unstructured":"Iazzolino B, Peotta L, Zucchetti JP, Canosa A, Manera U, Vasta R, Grassano M, Palumbo F, Brunetti M, Barberis M, Sbaiz L, Moglia C, Calvo A, Chi\u00f2 A (2021) Differential neuropsychological profile of patients with amyotrophic lateral sclerosis with and without C9orf72 mutation. Neurology 96:e141\u2013e152. https:\/\/doi.org\/10.1212\/WNL.0000000000011093","journal-title":"Neurology"},{"key":"11433_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.gde.2017.02.008","volume":"44","author":"S Van Mossevelde","year":"2017","unstructured":"Van Mossevelde S, Van der Zee J, Cruts M, Van Broeckhoven C (2017) Relationship between C9orf72 repeat size and clinical phenotype. Curr Opin Genet Dev 44:117\u2013124. https:\/\/doi.org\/10.1016\/j.gde.2017.02.008","journal-title":"Curr Opin Genet Dev"},{"key":"11433_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/hmg\/ddt460","volume":"23","author":"O Dols-Icardo","year":"2014","unstructured":"Dols-Icardo O, Garc\u00eda-Redondo A, Rojas-Garc\u00eda R, S\u00e1nchez-Valle R, Noguera A, G\u00f3mez-Tortosa E, Pastor P, Hern\u00e1ndez I, Esteban-P\u00e9rez J, Su\u00e1rez-Calvet M, Ant\u00f3n-Aguirre S, Amer G, Ortega-Cubero S, Blesa R, Fortea J, Alcolea D, Capdevilla A, Antonell A, Llad\u00f3 M-B, Mora JS, Gal\u00e1n-D\u00e1vila RD, Rivera FJ, Lle\u00f3 A, Clarim\u00f3n J (2014) Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum Mol Genet 23:749\u2013754. https:\/\/doi.org\/10.1093\/hmg\/ddt460","journal-title":"Hum Mol Genet"},{"key":"11433_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00401-015-1445-9","volume":"130","author":"E Suh","year":"2015","unstructured":"Suh E, Lee EB, Neal D, Wood EM, Toledo JB, Rennert L, Irwin DJ, McMillan CT, Krock B, Elman LB, McCluskey LF, Grossman M, Xie SX, Trojanowski JQ, Van Deerlin VM (2015) Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration. Acta Neuropathol 130:363\u2013372. https:\/\/doi.org\/10.1007\/s00401-015-1445-9","journal-title":"Acta Neuropathol"},{"key":"11433_CR33","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1093\/hmg\/ddv064","volume":"24","author":"A Nordin","year":"2015","unstructured":"Nordin A, Akimoto C, Wuolikainen A, Alstermark H, Jonsson P, Birve A, Marklund SL, Graffmo KS, Forsberg K, Br\u00e4nnstr\u00f6m APM (2015) Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD. Hum Mol Genet 24:3133\u20133142. https:\/\/doi.org\/10.1093\/hmg\/ddv064","journal-title":"Hum Mol Genet"},{"key":"11433_CR34","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S1474-4422(13)70210-2","volume":"12","author":"M van Blitterswijk","year":"2013","unstructured":"van Blitterswijk M, DeJesus-Hernandez M, Niemantsverdriet E, Murray ME, Heckman MG, Diehl NN, Brown PH, Baker MC, Finch NA, Bauer PO, Serrano G, Beach TG, Josephs KA, Knopman DS, Petersen RC, Boeve BF, Graff-Radford NR, Boylan KB, Petrucelli L, Dickson DW, Rademakers R (2013) Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol 12:978\u2013988. https:\/\/doi.org\/10.1016\/S1474-4422(13)70210-2","journal-title":"Lancet Neurol"},{"key":"11433_CR35","doi-asserted-by":"publisher","first-page":"1214.e1","DOI":"10.1016\/j.neurobiolaging.2013.11.034","volume":"35","author":"A H\u00fcbers","year":"2014","unstructured":"H\u00fcbers A, Marroquin N, Schmoll B, Vielhaber S, Just M, Mayer B, H\u00f6gel J, Dorst J, Mertens T, Just W, Aulitzky A, Wais LAC, Kubisch C, Weishaupt JH, Volk AE (2014) Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases. Neurobiol Aging 35:1214.e1-e6. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.034","journal-title":"Neurobiol Aging"},{"key":"11433_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-020-0359-8","volume":"15","author":"JL Jackson","year":"2020","unstructured":"Jackson JL, Finch NA, Baker MC, Kachergus JM, DeJesus-Hernandez M, Pereira K, Cristopher E, Prudencio M, Heckman MG, Thompson EA, Dickson DW, Shah J, Oskarsson B, Petrucelli L, Rademakers R, van Blitterswijk M (2020) Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers. Mol Neurodegener 15:7. https:\/\/doi.org\/10.1186\/s13024-020-0359-8","journal-title":"Mol Neurodegener"},{"key":"11433_CR37","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/ene.15243","volume":"29","author":"A Maranzano","year":"2022","unstructured":"Maranzano A, Poletti B, Solca F, Torre S, Colombo E, Far\u00e9 M, Ferrucci R, Carelli L, Verde F, Morelli C, Silani V, Ticozzi N (2022) Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis. Eur J Neurol 29:1402\u20131409. https:\/\/doi.org\/10.1111\/ene.15243","journal-title":"Eur J Neurol"},{"key":"11433_CR38","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s10072-020-04462-x","volume":"41","author":"B Poletti","year":"2020","unstructured":"Poletti B, Carelli L, Lunetta C, Ticozzi N, Silani V (2020) Advance care planning and mental capacity in ALS: a current challenge for an unsolved matter. Neurol Sci 41:2997\u20132998. https:\/\/doi.org\/10.1007\/s10072-020-04462-x","journal-title":"Neurol Sci"}],"updated-by":[{"DOI":"10.1007\/s00415-023-11651-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11433-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11433-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11433-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T12:10:57Z","timestamp":1678709457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11433-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["11433"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11433-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00415-023-11651-z","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00415-023-11651-z","URL":"https:\/\/doi.org\/10.1007\/s00415-023-11651-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"E.Colombo, B. Poletti, A. Maranzano, S. Peverelli, F. Solca, C. Colombrita, S. Torre, C. Tiloca, F. Verde, R. Bonetti, L. Carelli, C. Morelli report no disclosures. A. Ratti received research funding from AriSLA. V. Silani received compensation for consulting services and\/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb Srl, and Novartis Pharma AG. He receives or has received research support from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is on the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, and Frontiers in Neurology. N. Ticozzi received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He received research funding from the Italian Ministry of Health and AriSLA. He is Associate Editor for Frontiers in Aging Neuroscience.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}